WATERTOWN, Mass., June 01, 2024 (GLOBE NEWSWIRE) -- Werewolf Therapeutics, Inc. (HOWL), an innovative biopharmaceutical company pioneering the development of conditionally activated therapeutics ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results